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Abstract
Infections due to bacteria were once easily treated using antibiotics. However, the effective
shelf life of antibiotics is diminishing due to the rise and spread of antibiotic resistant bacteria.
Accordingly, novel approaches to treating infections are required. Pseudomonas aeruginosa is a
multi-drug resistant, biofilm forming opportunistic pathogen. A determinant of P. aeruginosa’s
pathogenicity is pyoverdine, a siderophore that is used to sequester iron from the environment.
After being produced by a bacterium, pyoverdine is secreted into the environment where it
complexes with iron. The pyoverdine-iron complex is then returned to the bacteria through
diffusion, where it drives the synthesis of additional pyoverdine. Accordingly, the relative
positions of bacteria and pyoverdine are important to facilitate access to this pyoverdine-iron
complex. Pyoverdine is critically important in the infection process as its removal or attenuation
results in decreased infection severity. Interestingly, previous studies have suggested that
periodically disrupting spatial structure of a bacterial population, through physical means, can
disrupt the ability of bacteria to access diffusible molecules required for growth. Based on this
previous work, we hypothesized that disrupting biofilms composed of P. aeruginosa biofilms using
physical disturbance would prevent accessibility to pyoverdine, which would ultimately reduce its
synthesis. To test this hypothesis, we periodically disturbed the spatial structure of a biofilm using
a microplate reader. We found that a disturbance frequency of 6 shakes/hr, we were able to
significantly reduce endpoint pyoverdine amount compared to the control frequencies of 0
shakes/hr and 30 shakes/hr. This observation was consistent when the density of biofilms was
increased using medium with increasing concentrations of glucose. Interestingly, we observed
periodic disturbance at 6 shake/hr could also disturb the ability of 20 different P. aeruginosa strains
isolated from the clinic to produce pyoverdine; in some cases, the amount of pyoverdine increased,
decreased, or stayed the same as a result of periodic disturbance. Overall, this suggests that the
ability to perturb pyoverdine production through periodic disturbance is not limited to a single
parameter space (one strain, one growth rate, one biofilm density), and instead may be observable
in strains and environments that lead to diverse biofilm densities. As pyoverdine is required for
the infection process, it is possible that our research might lead to novel strategies to reduce, or
prevent, infections due to P. aeruginosa.
Keywords: Pseudomonas aeruginosa, pyoverdine, disturbance, biofilm
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Introduction
Antibiotic resistance as a pressing medical problem
Infections due to bacteria were once easily treated using antibiotics. However, it is wellestablished that the effective shelf life of antibiotics is diminishing as bacteria acquire new
mechanisms that confer resistance [1, 2]. Further confounding this issue is the rapid spread of
antibiotic resistant bacteria in that they are growing in their global distribution. For example,
bacteria that carry extended spectrum β-lactamases, such as Pseudomonas aeruginosa and
Escherichia coli, can spread rapidly in the clinic and have been associated with causing significant
mortality and morbidity [3]. In the past decade, there has been a general lack of investment from
pharmaceutical companies in the identification and development of new antibiotics, which is
further confounding this issue. This lack of investment is often attributed to the large costs
associated with drug discovery and regulatory approval processes coupled with the rapid pace at
which bacteria apparently develop resistance [4]. When taken together, this has created the
‘perfect storm’ and has resulted in antibiotic resistant bacteria leading to extended hospital stays
[5] and increased mortality rates [6].
In a natural setting, antibiotic resistance occurs as natural interactions between antibiotic
producing microbes and antibiotic susceptible microbes co-evolve. Stated more simply, there is an
arms race between antibiotic producing and antibiotic susceptible microbes. These interactions
create a selective pressure that drives the evolution and selection of antibiotic-resistant individuals,
which eventually dominate the population. Often, selection by an antibiotic (e.g., the ribosome,
cell wall, DNA gyrase) drives a corresponding response. Mutations to susceptible genes can render
the antibiotic ineffective while continuing to allow the cell to divide. In fact, the arms race between
antibiotic producing and antibiotic susceptible microbes has likely always been occurring in
natural systems. Genes encoding resistance to several antibiotics including β-lactam and
glycopeptide antibiotics have been sequenced from 30,000 year old permafrost sediments [7]. This
principle can be extended to antibiotics that are used in the clinic where the use of aminoglycoside
antibiotics can drive structural changes in the ribosome [8], and the use of fluoroquinolones can
also drive changes in DNA gyrase [9]. As in a natural setting, this ultimately results in resistance.
One inherent drawback of the use of antibiotics that target a specific molecular structure is
the intense selective pressure that is placed on that structure. This has resulted in the use of
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combinatorial treatment strategies, such as the simultaneous use of multiple antibiotics. The notion
here is to layer selective pressures on two or more druggable targets. In theory, increasing the
targets of selection should reduce the likelihood of favorable mutations to confer sufficient
resistance, thus reducing the probability of evolving effective resistance. However, the
mechanisms by which antibiotics interact is complex, and can often result in antagonistic effects,
thus reducing overall efficacy. Furthermore, interactions between antibiotics can lead to adverse
complications in the patient. Thus, combinatorial treatment while evolutionarily salient is not
always plausible, especially in the clinical practice.
There has also been increased interest in limiting the use of antibiotics in general. For
example, the general use of antibiotics to treat unresponsive viral infections at the request of
concerned patients has now been limited [10]. In the agricultural setting, small doses of antibiotics
are often used to increase growth of livestock while reducing feeding rate [11]. Larger doses are
also used to maintain animal health [4]. This setting drives the selection of antimicrobial resistance
in livestock [12]. Moreover, antibiotics consumed by animals are often excreted into the
environment [4]. Such excreted antibiotics can then enter sewage systems and wastewater systems.
As above, selection pressure from these antibiotics can correspondingly lead to the development
of resistance in soil microbes. If such genetic determinants are found on conjugative plasmids they
can then be passed to their pathogenic counterparts. Due to the prevalence of antibiotic resistant
strains of bacteria, there is growing public attention to the consequences of antimicrobial resistance
or AMR [13]. Many governments have developed national AMR action plans to reduce
antimicrobial use, particularly in humans [13]. These policies include a wide range of policies
recommended by the WHO [13]. Educational approaches such as awareness campaigns and
guidelines were commonly used across all regions [13]. These educational approaches commonly
target individual prescribers, such as physicians, instead of altering healthcare structures to reduce
the overuse and misuse of antibiotics [13]. In addition to educational approaches, improving
sanitation and preventing the spread of infection is another necessary measure that can be taken to
reduce the use of antibiotics [14]. Preventing infection from occurring in the first place reduces
the need for subsequent treatment [14]. Additionally, limiting the use of antibiotics in agriculture
and aquaculture—particularly antibiotics being used to promote growth or prevent infection—
would also limit antibiotics entering the environment [14]. Reduction of antibiotic pollution
through animal, human, and chemical waste is also necessary to prevent the development of
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antibiotic resistant bacteria [14]. Overall improvement of global surveillance of drug resistance
and antimicrobial consumption in both humans and animals can provide an early warning system
for emerging threats and improve patient health [14]. Additionally, rapid diagnosis of patients
should also reduce antimicrobial prescriptions that are unnecessary [14] and promoting the
development of vaccines and alternatives to antimicrobials would also serve to limit use of
antibiotics [14]. Improving the number of people, the pay, and the recognition of people working
in infectious disease could allow for a greater ability to combat antimicrobial resistant bacteria as
well, allowing for more research [14].
Overall, there is an imperative need to determine novel strategies to control growth and
spread of bacteria involving imposing multiple selective pressures that reduce the potential of
evolved resistance in bacterial populations.

Pseudomonas aeruginosa
P. aeruginosa is a ubiquitous, Gram-negative, biofilm forming, pathogenic bacteria, that
causes infections in humans with compromised immune systems (e.g., transplant patients,
individuals who are HIV positive), in individuals with cystic fibrosis and other lung diseases,
people with traumatized corneas, burn patients, and long-term intubated patents [15]. The elderly
and those who have been in hospitals for extended periods of time are also susceptible to infection
by P. aeruginosa. Though the vast majority of the human population is not typically susceptible
to P. aeruginosa infections, this bacterium is able to adapt quickly in hosts that are susceptible
leading to long lasting and serious P. aeruginosa infections.
This bacterium can grow and thrive in a variety of different environments, including the
soil and the clinic, and is also widespread, which makes those susceptible to infection more likely
to come in contact with this pathogen. The bacteria, which are considered commensal on the host
body, can be transmitted through a breach in host tissue barriers or suppression of the host immune
system [15]. The ability for this bacterium to penetrate past these barriers allows it to become an
opportunistic pathogen. The global overuse of antibiotics has led to P. aeruginosa’s resistance
across a wide variety of antibiotics including many multi-drug resistant strains. As infections
caused by P. aeruginosa are resistant to multiple antibiotics, they can lead to persistent infections
causing secondary fungal infections, extensions of hospital stay, therapeutic failure, and premature
death of cystic fibrosis patients.
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Many naturally occurring and clinically acquired strains of P. aeruginosa are resistant to
multiple antibiotics including penicillin G, β-lactams, aminopenicillin, first and second generation
cephalosporins, piperacillin, tazobactam, cefepime, ceftazidime, aminoglycosides, quinolones,
carbapenems, colistin, and fosfomycin, which leads to severe and persistent infections in those
individuals who contract an infection [16]. For example, P. aeruginosa is the most prevalent of
all cystic fibrosis-related pathogens and it has the greatest impact on mortality and morbidity.
Outbreaks involving strains with resistance to multiple antibiotics are common in hospitals and
intensive care units leaving those patients susceptible to contracting a secondary infection. Overall,
given its prevalence in the environment and its ability to resist multiple antibiotics, developing
strategies to reduce or eliminate infections due to P. aeruginosa is important.

Biofilm structure & importance
Biofilms are highly organized, structured communities of bacteria attached to one another
and to a surface [17]. A biofilm is made up of surface-associated microbial cells enclosed in an
extracellular polymeric substance (EPS) matrix [18]. This EPS matrix in P. aeruginosa is made up
of exopolysaccharides, nucleic acids, and proteins [19]. Biofilms are considered to be robustly
associated with a surface and not able to be removed by gentle rinsing [18]. In P. aeruginosa,
activation of quorum-sensing [20] and the acquisition of sufficient iron [21] stimulates biofilm
formation [22]. Towards the former, P. aeruginosa’s quorum-sensing system involves several
autoinducers and the cognate receptors. One of these systems, the LasI/R system, produces and
detects autoinducers that are important for the formation of biofilms. For example, when LasR is
bound to its autoinducer, it activates expression of a number of target genes including virulence
factors such as elastase which is a structural gene [22-24]. This gene is critical in the formation of
biofilms as they encode for the LasR protein which is a transcriptional activator. The resulting
production of pyoverdine to sequester sufficient iron subsequently drives the subsequent formation
of biofilms [25]. In the LasR system, LasR binds to the promoter region of the psl operon,
suggesting regulation of psl expression [26]. In addition, two more systems RhlR (which is
controlled by the LasR system) and the PQS system, which is based on quinolone signals are also
present. The rhl system enhances pel polysaccharide biosynthesis [26]. Both psl and pel serve as
a primary structure scaffold for biofilm development, particularly in early stages of formation [26].
The rhl system also controls swarming motility, which is implicated in early biofilm establishment
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[26]. Mutations in the PQS system result in reduced biofilm formation and the reduction of the
production of virulence factors which is implicated to play a role in biofilm development [15].
Biofilms composed of P. aeruginosa are commonly found in prosthetic devices, medical implants,
and heart, lung, and bladder infections [27].
Biofilm formation in P. aeruginosa involves two sequential events [19]. First, a bacterial
cell contacts the surface it will form an attachment to and forms a reversible attachment [19].
Second, this cell then begins to produce the EPS matrix [19] using genes primarily found in the
pel operon [28]. This EPS matrix is credited to structuring the mature biofilm [19]. Biofilm
architecture can be influenced by nutritional cues, motility, and quorum sensing [22]. For example,
P. aeruginosa biofilms grown in media where glucose is used at the carbon source take on the
mushroom shaped topology [22]. Otherwise, with lactoferrin nutrients, biofilms take on a flat
topology formed by sheet-like layers [22].
Bacteria growing in biofilms and in planktonic conditions have shown to have distinct
antibiotic susceptibilities, growth rates and gene expression profiles. Cells within the biofilm have
a slower growth rate than their planktonic counterparts, which may be due to oxygen and nutrient
limitation within the biofilm [17]. This slowed growth reduces the efficacy of certain, but not all
antibiotics, including -lactam antibiotics that rely on active cell wall synthesis to result in cell
death. In addition to slow growth, antibiotics can often fail to reach cells embedded inside the
biofilm at inhibitory concentrations. Such sub-inhibitory concentrations of antibiotics can
contribute to the evolution of antibiotic resistance as described above. Finally, due to their high
density, bacteria often express different genes in biofilms in comparison to their planktonic
counterparts [18]. These include virulence factors that are regulated through quorum sensing.
Biofilms of P. aeruginosa, in particular, have shown to have a higher resistance to
antibiotics, such as penicillin G, β-lactams and second generation cephalosporins. P. aeruginosa
infections are often found growing in iron limiting conditions in a biofilm [27]. P. aeruginosa
biofilms, like other Gram-negative bacterium, grows slowly in these iron limiting conditions [29].
Cells growing at a slower rate, such as those in the biofilm, take up and process antibiotics slower.
This is due in part to the antibiotic’s inability to penetrate the EPS matrix of the biofilm [27] In
addition, virulence factors such as pyoverdine and pyocyanin production, hydrogen cyanide,
elastase, rhamnolipids, protease production, and lipopolysaccharide production, are present when
cells are in biofilm state, also reduce susceptibility to antibiotics. This includes bacteria that have
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been dislodged from the biofilm and placed in the planktonic state due to the continued presence
of virulence factors. As the growth rate of these dislodged cells increases, their susceptibility to
antibiotics increases [6].
Spatial structure, including biofilms, has been previously shown to allow sequestration of
important small molecules [30]. P. aeruginosa is no different. Important growth factors, such as
pyoverdine, and autoinducers involved in quorum sensing accumulate faster in biofilms. This
owed to the spatial distribution of the cells, and the diffusion of the small molecules. Although
small molecules will diffuse away from a biofilm, they will accumulate faster inside the biofilm
allowing rapid synthesis by a large population of cells. The accumulation of these autoinducers
and small molecules in the biofilm play a role in activating the aforementioned virulence factors
in P. aeruginosa. One of these small molecules which accumulates in the biofilm and leads to the
activation of virulence factors is the siderophore pyoverdine, produced by P. aeruginosa to
scavenge for iron from the surrounding host matrix.
Pyoverdine – a siderophore required for infections
In environments with a scarcity of free iron, such as most areas in the human host, bacteria
will use siderophores to sequester iron from the host. Pyoverdine is a naturally fluorescent
diffusible peptide siderophore produced by P. aeruginosa strains to sequester iron from the
environment [31]. Pyoverdine is commonly studied in P. aeruginosa due to its green fluorescent
color making it clearly visible in colony growth. Once produced, pyoverdine is transported out of
the cell where it can bind to iron in the environment. Once pyoverdine is released into the
extracellular environment, it diffuses and forms a complex with iron [31]. After acquiring iron,
pyoverdine-iron complexes are taken up through receptor proteins and the iron is released and used
within the cell for incorporation into proteins. The pyoverdine peptide can then be re-transported
out of the cell where is can harvest additional iron.
The production of pyoverdine in P. aeruginosa has often been considered as cooperative
behavior [15, 32] and qualifying as a public good (27) as individuals within the colony benefit
from pyoverdine but do not all share equally in the costs of its production. However, the
distribution of pyoverdine is limited locally within P. aeruginosa biofilms thus allowing for those
cells producing the pyoverdine to disproportionately benefit from its production as well as limit
its exploitation by non-producing strains. In many of the habitats where P. aeruginosa is
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commonly found, outside of the biofilm iron-seeking siderophores would not get back to the
producing cells making its production paradoxical. Taken together, biofilm formation helps both
sequester pyoverdine in a local environment benefiting all biofilm cells, while also bias the
distribution of pyoverdine around producing cells thus stabilizing cooperation within the
collective.
Pyoverdine is an essential virulence factor in P. aeruginosa. Studies performed in mice
have demonstrated that removing pyoverdine through gene deletion significantly attenuates
pathogenicity. In these pyoverdine deficient strains, under iron starved conditions they produced
about 40% less pyoverdine than a wild type strain [33]. These pyoverdine deficient strains were
then used to infect mice resulting in no fatalities [33]. In another study involving mice, the level
of pyoverdine production and accumulation in the lungs was correlated with the severity of disease,
supporting the correlation between virulence and pyoverdine [34, 35]. Accordingly, pyoverdine is
required for establishing infection and for subsequent biofilm formation.
Pyoverdine has a complex bidirectional regulatory relationship with biofilm formation in
P. aeruginosa [36]. Pyoverdine is responsible for obtaining extracellular iron, which is essential
for biofilm development under iron starved conditions [36]. Similarly, pyoverdine production is
regulated by biofilm formation when it is not in an iron-starved state [36]. Iron deficiency in P.
aeruginosa leads to the expression of genes involved in iron acquisition, including the
siderophores pyochelin and pyoverdine, iron transporters haem and feo, exoenzymes to cleave
iron-bound host proteins, and other redox enzymes and toxins [15]. Pyoverdine is initially
synthesized in the cytoplasm by non-ribosomal peptide synthetases including PvdL, PvdI and
PvdD [37-39]. It is then subsequently transported into the periplasmic space by the ABC
transporter PvdE where it matures [40]. Matured pyoverdine is then transported into the
extracellular environment using the PvdRT-OpmQ efflux pump [41]. Once in the extracellular
environment, pyoverdine will complex with ferric iron (Fe3+) forming ferripyoverdine [42], which
is subsequently transported across the periplasmic membrane into the periplasmic space using the
FpvA/B transporter [43, 44]. Once in the periplasmic space, iron is released from ferripyoverdine,
which is subsequently transported across the cell membrane using the FpvDE transporter [45].
Upon disassociation from ferric iron, pyoverdine will be recycled as it is re-transported into the
extracellular environment [46]. In addition to sequestering iron from the environment,
ferripyoverdine has additional downstream effectors that are important in biofilm formation [47]
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and virulence [48, 49]. Binding of ferripyoverdine to the FpvA transport protein results in the
activation of an alternative sigma factor called PvdS [50]. Activation of PvdS leads to the
expression of virulence factors, including exotoxin ToxA and the endoproteinase PrpL. It also
leads to additional synthesis of pyoverdine, thus forming a positive feedback loop [30]. The
positive feedback loop can be attenuated if sufficient iron is internalized. In short, intracellular
iron binds to Fur, which represses PvdS [51] as well as the subsequent production of pyoverdine
[52]. Fur also plays a role in the regulation of biofilm formation [53] and the expression of
virulence factors [51].
Given importance of pyoverdine in growth, expression of virulence factors, and biofilms
production, there is increased interest in developing mechanisms to interfere with its functionality
[30]. Compromising biofilm development by either genetic (such as mutations in genes that
contribute to biofilm formation like pel biosynthesis and PQS synthesis) or chemical disruption
(with novel inhibitors such as meta-bromo-thiolactone, 2-aminoamidazole derivatives, and
zingerone) [20, 54, 55] decreased pyoverdine biosynthesis in P. aeruginosa [30].

Flourinated

pyrimidines strongly attenuate P. aeruginosa pathogenesis, likely by compromising RNA
metabolism. Pyoverdine production could be limited by 5-flurouracil, which also temporarily
restricts bacterial growth, and 5-fluorouridine [56]. Gallium, a transitional metal, can also be used
to disrupt bacterial Fe metabolism through being a substitute for iron and inhibiting iron dependent
processes [57]. In addition, a study found four novel compounds which were able to quench more
than half of pyoverdine fluorescence, LK10, LK11, LK12, and LK 31 [35]. Overall, methods to
disrupt pyoverdine functionality and expression in P. aeruginosa are highly desirable as they may
attenuate pathogenicity of this important opportunistic pathogen.

Perturbing spatial structure as a mechanism to break up cooperation
Previous studies have shown that disrupting spatial structure, including through physical
means, can disrupt cooperation and influence growth. Recently, Wilson et al. demonstrated that
intermediate frequencies of spatial disturbance of spatially structured populations could
manipulate cooperation in E. coli [58]. Guided by a mathematical model, the authors revealed that
spatial disturbance at intermediate frequencies resulted in a trade-off between accessing small
molecules required for cooperation and survival and accessing nutrients, which impacted growth.
When access to both was limited, the ability to use the small molecules required for cooperation
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was disrupted. Given the diffusible and essential nature of pyoverdine to cell growth, we reasoned
that periodically disrupting the spatial structure of a biofilm would reduce the access to pyoverdine.
This would occur as disrupting the spatial structure would serve to decorrelate the relative
positions of bacteria and pyoverdine, including bacteria removed from the biofilm state. Reducing
access to pyoverdine would subsequently reduce the synthesis of additional pyoverdine by
attenuating the positive feedback loop driven by iron acquisition. By placing the selective pressure
on multiple aspects of cell physiology (pyoverdine synthesis, iron acquisition, biofilm formation)
there is the potential that this represents a new way to disrupt pyoverdine functionality without
driving resistance.

Questions and hypotheses:
The overarching goal of this project is to explore the ability to perturb pyoverdine
production in P. aeruginosa using physical disruption of biofilms. My hypothesis is pyoverdine
production in P. aeruginosa will be reduced when the structure of biofilms are disrupted using
physical force. Within this overarching goal, we propose three aims: (1) determine how periodic
physical disturbance using intermittent shaking changes pyoverdine production in P. aeruginosa,
(2) determine if changes in biofilm robustness affects how periodic physical disturbance influences
pyoverdine synthesis, (3) determine the effect of periodic disturbance on P. aeruginosa strains
isolated from the clinic. We believe our research is significant as physical disruption of pyoverdine
production will affect biofilm robustness and virulence of P. aeruginosa. This line of research
could subsequently lead to the development of new mechanisms to combat P. aeruginosa
infections in humans. We believe our research is innovative as, unlike previous studies (which
used starvation techniques [59, 60] or multiple antibiotics [61, 62]), we propose to use physical
force, which may be less prone to evolved resistance as it imposes selection over several potential
targets.
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Methods and Materials
Strains and growth conditions
P. aeruginosa strain PA14 was used as the wildtype strain in this study. Additional clinical
isolates were obtained from BEI Resources (Table 1). Where indicated, we also used a strain of P.
aeruginosa PA14 that lacks the ability to form biofilms (-pel, [63]). All experiments were
performed in modified King’s A medium [2% peptone, (Fisher Scientific, Waltham, MA), 0.5%
potassium sulfate, (Acros Organics, Fisher Scientific), 17 mM magnesium chloride (Alfa Aesar,
Parkridge Road Ward Hill, MA) with and without different concentrations of carbon source (0%,
1% or 2% glucose (VWR, Radnor, PA)). Single colonies of P. aeruginosa isolated from LuriaBertani (LB) agar medium (MP Biomedicals, Solon OH) were shaken overnight (250 RPM and
37oC) in 3 mL of liquid LB medium contained in culture tubes (Genesee Scientific, Morrisville,
NC). As indicated in the text, gallium nitrate (Acros Organics) was added to a final concentration
of 10uM gallium modified King’s A medium. We used the Innovotech (Edmonton, AB, Canada)
MBEC Biofilm Inoculator to grow biofilms [64]. We grew overnight cultures of P. aeruginosa,
washed the cells in fresh King’s A medium, and diluted 1000-fold them into fresh modified King’s
A medium. We then placed 150 L of culture into the wells of the biofilm plate and allowed the
biofilm to form by shaking the plate at 110 RPM at 25oC for 24 hours.

Biofilm staining
We followed the protocol as outlined in [65]. Briefly, we grew biofilms as described above.
After 24 hours, we washed the pegs (which remained attached to the lid of microplate) with 200
µL of fresh modified King’s A medium for 10 seconds to remove any unadhered cells. Next, the
washed pegs were placed in 125 µL of 0.1% Crystal violet (Acros Organics) for 10 minutes. We
then washed the stained pegs in 200 µL of ddH2O four times to as to remove any excess crystal
violet. Finally, we transferred the pegs to 200 µL of 30% acetic acid (Fisher Scientific) for 10
minutes to remove crystal violet from the biofilms. The amount of solubilized crystal violet was
measured using optical density (OD) at 555 nm in a Victor X4 plate reader (Perkin Elmer,
Waltham, MA). OD555 values were blanked using acetic acid.
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Dispersal of cells from the biofilm due to shaking
We grew biofilms in modified King’s A medium as described above. After 24 hours of
growth, we removed the plate, and washed the pegs for 10 seconds in 200 L of fresh King’s A
medium to remove any unadhered cells. The washed biofilms were placed in 200 L of fresh
modified King’s A medium, and the plate was placed in a Victor X4 plate reader pre-set to 25oC.
The biofilms were then shaken once at the amplitude indicated and were subsequently removed
from the plate reader. We then measured the number of colony forming units in the King’s A
medium surrounding the plate as previously described [66].

Shaking experiments
We grew biofilms in modified King’s A medium as described above. After 24 hours of
growth, we removed the plate, and washed the pegs for 10 seconds in 200 L of fresh King’s A
medium. The washed biofilms were placed in 200 L of fresh modified King’s A medium, and the
plate was placed in a Victor X4 plate reader pre-set to 25oC. The plate was then periodically shaken
(fast setting, frequency = 4800 mm/min, 10 seconds per shake, linear shaking feature which shakes
the plate along the x-axis) at the frequency indicated in the results. Note that the Victor X4 plate
reader does not have a continuous shaking function. Thus, a shaking frequency of 30 shakes/hr
was used as a continuous shaking control. After 24 hours of growth in the plate reader, we removed
the lid from the plate and measured cell density (OD600) and the concentration of pyoverdine
(excitation: 405 nm, emission: 460 nm) using the Victor X4 microplate reader. Pyoverdine
(arbitrary units) was normalized by OD600.

Measuring expression of green fluorescent protein
We prepared competent P. aeruginosa PA14 as described previously [67]. We transformed
these cells with plasmid pAB1 [68], which contains an isopropyl β-D-1-thiogalactopyranoside
(IPTG) inducible copy of enhanced green fluorescent protein (GFP), and confers ampicillin
resistance. To measure the effect of periodically disturbing the spatial structure of the expression
of GFP, we grew biofilms of these GFP expressing bacteria as described above. After washing the
pegs to remove any unadhered cells, we placed the biofilms into fresh modified King’s A medium
that contained, or did not contain as a control, 1 mM IPTG (Thermo Scientific, Lithuania). We
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then disturbed the spatial structure of these biofilms as described above. After 24 hours, we
quantified cell density (OD600) and GFP (excite: 488 nm, emission: 510 nm) using the Victor X4
microplate reader. GFP was normalized by OD600.

Growth rate
We grew P. aeruginosa overnight as described above. The following day, strains of P.
aeruginosa were washed once in modified fresh King’s A medium. They were then diluted 1/100
into fresh King’s medium with different percentages of glucose. 200 L of diluted cells were then
placed in the wells of a 96 well plate, which was subsequently shaken at 25 oC at 250 RPM. After
4 hours of growth, we then measured OD600 every hour for a total of five additional hours using a
microplate reader. To determine growth rate, we plotted a linear line through a plot of OD 600 vs
time and determined the slope. All lines had R2 values greater than 0.9.

Statistical analysis
We used unpaired t-tests (with unequal variance between the samples) or one-way
ANOVA as indicated in figure legend. T-test analysis was performed using Microsoft Excel
(Redmond, WA). ANOVA and linear regression were performed using JASP (Amsterdam, the
Netherlands).
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Results
An experimental approach to disturbing the spatial structure of biofilms.
First, we established a method to grow and periodically disturb the spatial structure of P.
aeruginosa biofilms. We used the MBEC Biofilm inoculator plates to grow biofilms (Figure 1
[49]). The MBEC Biofilm Inoculator plates are 96 well plates with pegs adhered to the inside
surface of the plates lid. This system allows biofilms to form on the peg while it sits inside a well
containing growth medium. In addition to the biofilm that forms on the peg, bacteria in the
planktonic state grow in the liquid media surrounding the peg. The biofilms adhered to the pegs
can be washed and transferred to different growth medium by removing the lid of the original 96
well plate and transferring the lid into a new 96 well plate. We confirmed the growth of biofilms
on the pegs by first growing biofilms in the MBEC Biofilm Inoculator plate for 24 hours and used
crystal violet staining to confirm the presence of the biofilm grown (Fig. 2).
We then disrupted the spatial organization of the biofilm through periodic disturbance of
its spatial structure. Here, we relied on previous work [58] that demonstrated the shaking setting
of a microplate reader perturbs the spatial organization of structured bacterial populations, such as
the population of a biofilm. We hypothesized shaking a biofilm would remove cells from the
biofilm and transition them into the surrounding liquid medium and into the planktonic state. For
confirmation of this transition, we measured the density of bacteria in the biofilm and planktonic
states both before and after a single shaking event (Fig. 3). Using this single shaking event, we
observed this method both decreased the density of bacteria in the biofilm while also increased the
density of bacteria in the planktonic state (Fig. 3). We also observed that increasing the amplitude
of a single shaking event increased the density of bacteria in the planktonic state (Fig. 4). This
produced a positive linear relationship between shaking amplitude and the amount of bacteria in
the planktonic state (R2=0.99, linear line, Fig. 4). Overall, these observations demonstrate that a
single shaking event was sufficient to perturb the spatial structure of a biofilm.

Periodically disturbing the spatial structure of biofilms alters the amount of pyoverdine per cell.
In an iron limited environment, P. aeruginosa requires pyoverdine for growth [69]. P.
aeruginosa uses pyoverdine for the import of iron which results in cell division. The increase in
biomass via cell division also leads to the production of additional pyoverdine; in addition, the
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import of iron through ferripyoverdine also increases pyoverdine synthesis through PvdS [70]. The
relationship between pyoverdine synthesis and growth follows a positive feedback loop in an iron
limiting environment.
To disrupt the positive feedback loop, we changed the distribution of cells in both the
biofilm and planktonic states. We hypothesized that changing this positive feedback loop would
disrupt the ability of bacteria in the biofilm to access ferripyoverdine. To disrupt this positive
feedback loop, we grew biofilms of P. aeruginosa using the MBEC inoculator system for 24 hours.
We then used the linear shaking function of a plate reader for an additional 24 hours to perturb the
spatial organization of the biofilm. After these 24 hours, pyoverdine was quantified and normalized
by cell density (OD600). We observed that frequencies of 6 (6/hr) and 12 (20/hr) shakes per hour
reduced the normalized pyoverdine in comparison to both unshaken and 30 shakes per hour control
(this 30 shakes per hour control in our system was used as a surrogate for near continuous shaking
(Fig. 5)). We also determined that no other shaking frequencies (aside from the aforementioned
6/hr and 12/hr) differed significantly from both control conditions (unshaken and 30/hr). We
verified the majority of pyoverdine we measured was located in the planktonic bacteria and not
within the biofilm by comparing the normalized pyoverdine of the planktonic bacteria and also the
normalized pyoverdine located in the biofilm by resuspending the biofilm bacteria in media and
measuring (Fig. 6). We verified that the reduction of pyoverdine at 6 shakes/hr was not due to
general perturbations in either transcription or translation through an eGFP-expressing P.
aeruginosa (Fig. 7). This GFP-expressing P. aeruginosa was grown under the same conditions
and normalized by cell density generally increased as function of shaking frequency (Fig. 7).
Next, we examined the influence of biofilm formation on the reduction in pyoverdine at 6
shakes/ hr. This was investigated in a strain of P. aeruginosa that does not form biofilms (-pel)
(Fig. 8). The strain was cultured as described above and disturbed at various shaking frequencies.
We observed no significant decrease or increase in the amount of normalized pyoverdine across
all measured frequencies (Fig. 8).We also observed an overall reduction in the total amount of
pyoverdine produced, confirming previous observations that biofilm formation enhances
pyoverdine synthesis [69]. These results also suggest that the reduction of pyoverdine production
at 6 shakes/hr is dependent on the ability to form a biofilm.
We then perturbed the production of pyoverdine using the element gallium. Previous work
has indicated that gallium binds to pyoverdine with high affinity, thus disrupting both its
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functionality and discouraging production [57]. When we grew wild-type P. aeruginosa in the
same way as previously described and included gallium in the medium, we observed a significant
reduction in overall normalized pyoverdine (Fig. 9). In addition, there was no significant reduction
in normalized pyoverdine relative to the unshaken (0/hr) and 30/hr control conditions compared to
all other shaking frequencies tested. These results suggest a reduction in pyoverdine at 6 shakes/hr
is dependent on pyoverdine functionality. Overall, our analysis suggests that, a reduction in
normalized pyoverdine at 6 shakes/hr is dependent on the ability of P. aeruginosa to both form a
biofilm and to use pyoverdine to acquire iron (Fig. 9).

Increasing the percentage of glucose in growth medium increases the range of shaking
frequencies that reduce amount of pyoverdine synthesized.
Given that biofilm functionality appeared to be critical in the observed decrease of
pyoverdine synthesis at 6/hr, we then sought to perturb the ability of P. aeruginosa to make
biofilms. Previous work [71] has indicated that increasing the percentage of glucose in growth
medium increases the ability of P. aeruginosa to form biofilm. However, it does not appear to alter
growth rate (Fig. 10). Thus, this perturbation could separate the effects of biofilm formation and
basal growth rate owing to central carbon metabolism. Given this information, we examined how
periodic shaking affects pyoverdine synthesis when biofilms increased in robustness by increasing
the concentrations of glucose in the growth medium.
We determined that we could increase the amount of pyoverdine synthesized by
undisturbed biofilms by increasing the amount of glucose in the medium (Fig. 11). Furthermore,
and as previously reported [71] increasing growth had no apparent effect on growth rate (Fig. 10).
Next, we tested the influence of periodic disturbance on pyoverdine production in medium with
increasing percentages of glucose. Here, we focused on a shaking frequency of 6/hr as it resulted
in the greatest decrease in pyoverdine synthesis as shown in Fig. 11. We observed that as the
concentration of glucose was increased in the medium, the total amount of pyoverdine consistently
decreased in the 6/hr condition as compared to the unshaken (0/hr) and 30/hr conditions. While
the total amount of pyoverdine produced in the 6/hr condition generally increased as a function of
glucose concentration, the difference in pyoverdine between the control conditions was
statistically equivalent across conditions. Overall, we observed that the shaking frequency of 6/hr
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consistently resulted in decreased pyoverdine as the amount of glucose increased in the growth
medium. Thus, periodic shaking influenced pyoverdine production even for robust biofilms.

Pyoverdine production is significantly affected by intermediate concentration of glucose across
a large number of P. aeruginosa strains isolated from the clinic.
The above findings led to further investigate whether these relationships could be
replicated in 20 different P. aeruginosa strains isolated from the clinic. These 20 different strains
represent a wide range of biofilm forming capabilities (Fig. 12) and a wide range of growth rates
(Fig. 12). This diverse set of strains allowed us to examine if the whether the effects of periodic
disturbances on biofilm formation are generalized across a diverse set of physiological parameters.
Biofilms grown from all 20 strains of P. aeruginosa were subsequently disturbed at the
frequency of 6 shakes/hr, as 6 shakes/hr consistently resulted in a significant reduction of
normalized pyoverdine produced across different percentages of glucose (Fig. 12). Furthermore,
the undisturbed (0/hr) condition served as the baseline control as there was no significant
difference in pyoverdine production between 0/hr and 30 shakes/hr (P > 0.360 within all
percentages of glucose, two-tailed t-test).
Using crystal violet, we observed a significant and positive linear correlation between
initial biofilm density and corresponding change in biofilm density as a result of shaking. The
denser the biofilm produced by a strain in an undisturbed condition, the greater the decrease in
density as a result of shaking (Fig. 12).
Next, we plotted the amount of pyoverdine produced under undisturbed conditions (0
shakes/hr) as a function of the amount of pyoverdine produced when biofilms were disturbed at 6
shakes/hr for all 21 strains of P. aeruginosa studied in this thesis (20 strains from the clinic and
our wildtype PA14 strain). These two endpoint measurements depict an observable, significant,
and positive linear correlation for strains grown in medium with increasing percentages of glucose.
Using this analysis, we demonstrate amount of variation in bacterial growth attributed to glucose
in the medium (R2) was substantially less in 1% glucose medium (R2 = 0.45) than for bacteria
grown in either 0% or 2% glucose (R2= 0.8 and R2=0.94, respectively) (Fig. 13).
In further investigation, we examined the change in biofilm density due to shaking using
crystal violet staining and tracked resulting changes in density of planktonic bacteria using OD600.
To determine the effective change in each of these measurements, we subtracted the measurements
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taken at 6 shakes/hr from the measurements taken for the undisturbed condition (Fig. 15 & 16).
With this analysis, a negative value indicates an increase in each metric as a result of shaking, with
positive values demonstrating the opposite. Overall, we found that as the percentage of glucose in
the medium was increased, the difference in biofilm density due to shaking significantly increased.
In addition, we observed a biphasic relationship between the change in the density of bacteria in
the planktonic state due to shaking. The change in density of planktonic bacteria in 1% glucose
media was significantly greater than the change of planktonic bacteria in 0% glucose and of 2%
glucose media. Across a diverse set of P. aeruginosa strains, we found that when we included 1%
glucose in the growth medium, a significant difference in the distribution of bacteria compared to
the 0% and 2% glucose media conditions was observed.

A decrease in the amount of pyoverdine at intermediate glucose concentration is largely owing
to reduction in biofilm density.
Next, we examined how shaking differentially alters pyoverdine production across the
spectrum of individual strains grown in 1% glucose media. We observed a substantial increase in
the number of strains that had a statistically significant change in pyoverdine in medium containing
1% glucose compared to the 0% glucose and 2% glucose media (Fig. 14). Overall, these changes
were diverse, with pyoverdine increasing in some instances whereby decreasing in other.
Strains were subsequently grouped with one group involving those that had significant
changes in pyoverdine due to shaking and the other containing those that did not have significant
changes in pyoverdine due to shaking. We also examined the change in biofilm density and the
change in bacteria density in the planktonic state as described previously. In 1% glucose medium,
we observed a significant reduction in biofilm density due to shaking between the strains that were
significantly affected by or not significantly affected by shaking (Fig. 18). We also examined the
relationship between difference in pyoverdine amount between undisturbed and 6 shakes/hr as a
function of growth rate. No linear correlation was found with any condition (Fig. 17). We
examined the change in biofilm density as a result of shaking at 6 shakes/hr as a function of
percentage of glucose in the growth medium and found that there was only a statistically significant
decrease in biofilm density in media with 1% glucose (Fig. 19). We also observed, in contrast to
the above, that across glucose conditions, there was no significant difference in the density of
bacteria in the planktonic state (Fig. 20). Both of these observations together indicate that changes
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in pyoverdine production attributed to shaking are largely dependent upon the ability of shaking
to significantly affect biofilm structure.
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Discussion
Previous studies have shown that disrupting the structure of a spatially organized
population of bacteria, including through physical means, can disrupt cooperation and influence
growth [58]. Given this backdrop, we explored the ability to disrupt the spatial structure of P.
aeruginosa biofilms to disrupt pyoverdine production. This was accomplished by establishing a
method using the MBEC Biofilm assay plate coupled with the shaking feature of a microplate
reader. This allowed us to be able to measure, and perturb, the distribution of bacteria in both
biofilm and planktonic states (Fig. 1). Using the set up as described, we confirmed the presence of
biofilms using crystal violet staining (shown in fig. 2). Once it was determined P. aeruginosa
biofilms could be produced, we determined whether shaking these biofilms effectively dislodge
cells from the biofilm. Using colony forming units, we determined that shaking was able to remove
cells from the biofilm and transfer them into planktonic state (fig. 3). Along this line, we observed
both a decrease in CFUs in the biofilm and an increase in cells in planktonic media after shaking
in comparison to measurements taken prior to shaking. In addition, when the density of bacteria in
the planktonic state was normalized by biofilm density, we continued to observe an increase in the
density of bacteria in planktonic state after shaking. Finally, we examine the impact that increased
shaking amplitude had on the ability to transfer bacteria from the biofilm state to the planktonic
state. We found that as shaking amplitude increased, the density of bacteria in the planktonic state
increased (Fig. 4). Overall, we established that bacteria can be experimentally transitioned from
the biofilm state to the planktonic state thus perturbing the spatial organization of this closed
system. As pyoverdine is freely diffusible, altering the positions of bacteria in both states
decouples the distribution of pyoverdine and bacteria. In all, our experiments demonstrate the
potential to disrupt the ability of P. aeruginosa to access pyoverdine through periodically applied
physical force.
After determining we could dislodge cells from the biofilm using the designed shaking
protocol, we explored the impact of shaking frequency (number of shakes/ hr over 24 hours) on
the amount of pyoverdine present in the medium surrounding the biofilm. Importantly, we
confirmed that the majority of pyoverdine produced in our closed experimental system could be
measured in the liquid medium surrounding the peg whereupon the biofilm grew. This was
expected as each pyoverdine molecule is freely diffusible from the producing cell. Thus, even for
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bacteria in the biofilm state, most of the pyoverdine ultimately ends up in the surrounding medium
(Fig. 6). Focusing on measuring the amount of pyoverdine in the surrounding liquid medium, we
tested a wide range of shaking frequencies in growth medium containing 0% glucose and measured
endpoint pyoverdine after 24 hours of disruption (fig. 5). Across this spectrum of frequencies, we
found the 6 shake/hr frequency resulted in significantly lower amounts of endpoint pyoverdine in
comparison to both the undisturbed (0) shakes/hr condition and the nearly continuous 30 shakes/hr
condition. In theory, as the frequency of shaking increases, an increasing amount of bacteria are
removed from the biofilm and transferred into the surrounding medium. In the undisturbed
condition, or without shaking, we would expect that the vast majority of bacteria would be in the
biofilm state and that bacteria in the surrounding medium would be present as a result of sloughing
off of the biofilm or active dispersal mechanisms. In this condition, because the biofilm is not
disturbed, we would expect that the amount of pyoverdine would be high owing to a highly
spatially organized population, which facilitates access to pyoverdine. In contrast, in the 30
shakes/hr condition, the near continuous disturbance of the biofilm would result in a large amount
of bacteria in the planktonic state, with a relatively small biofilm. While bacteria under this
condition would not benefit from increased access to pyoverdine owing to spatial organization,
they would instead benefit from increased access to nutrients. Based on a previous publication,
this would drive increased growth, which would increase the amount of pyoverdine synthesized
due to increased total cell density. This would effectively compensate for a reduction in access to
pyoverdine via spatial organization, thus allowing pyoverdine synthesis to remain high.
Between these two extremes, different frequencies of shaking serves to alter the relative
densities of both populations; increasing shaking should increase the amount of bacteria in the
planktonic state. Based on this notion, we suggest the shaking frequency of 6 shake/hr condition
presents a ‘sweet spot.’ Here, the population of cells in the biofilm state is not sufficiently dense
resulting in less pyoverdine build up within the biofilm. This results in these cells having less
access to pyoverdine. In addition, the shaking is not frequent enough to transition sufficient
bacteria into the planktonic state to take advantage of the potential of increased growth rate. Thus,
cells in the planktonic state do synthesize additional pyoverdine to compensate for reduced spatial
organization in the system. Overall, this results in a general reduction in the total amount of
pyoverdine synthesized by the population.
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Providing evidence towards our hypothesis, we performed three important controls. First,
we used a gfp expressing strain of P. aeruginosa to determine that the reduction at 6 shakes/hr was
specific to pyoverdine, and not additional protein products that could be perturbed by changing
translation (Fig. 7-9). Consistent, with our hypothesis, we did not observe a significant decrease
in normalized GFP at 6 shakes/hr as compared to the unshaken and near continuously shaken
controls (Fig. 7). Next, to confirm that the observed decrease in pyoverdine was due to changes to
the structure of a biofilm, we utilized a strain of PA14 (-pel) that does not form biofilms. We did
not observe a reduction at 6 shakes/hr and noted that overall pyoverdine synthesis declined (Fig.
8). This led to two important conclusions. First, and consistent with previous publications, biofilm
formation is required for robust pyoverdine synthesis. Second, it demonstrated that the reduction
in pyoverdine at 6 shakes/hr requires the formation of a biofilm. Finally, we tested the ability of
pyoverdine synthesis to be perturbed by gallium. As noted above, gallium binds with high affinity
to pyoverdine and disrupt its ability to acquire iron and drive the synthesis of additional
pyoverdine. We observed that the addition of gallium to growth medium results in a significant
reduction in normalized endpoint pyoverdine compared to the wild type strain grown without
gallium (Fig. 9). Furthermore, a reduction at 6 shakes/hr was not observed. This suggested that
pyoverdine functionality was required to observe a reduction of pyoverdine amount at 6 shakes/hr.
Overall, these control experiments provide evidence to three important assumptions of our
hypothesis and mechanism describe above; 1) the reduction in pyoverdine at 6 shakes/hr is not due
to general perturbation of transcription and translation, 2) biofilm formation is required to reduce
pyoverdine at 6 shake/hr and 3) functional pyoverdine is required for the observed decrease at 6
shakes/hr.
A previous study found that increasing glucose in the growth medium increased the density
of biofilms but did not apparently increase growth rate of cells in the planktonic state. Indeed, we
confirmed the latter by observing that increasing glucose produced no significant effect on growth
rate of bacteria grow in liquid culture (Fig. 10). Thus, we could increase biofilm density without
changing basal growth rate by increasing the amount of glucose in the growth medium. In all three
tested glucose concentrations (0%, 1%, and 2%), the 6 shakes/hr condition resulted in significant
reductions of pyoverdine at (Fig. 11). In addition, we also observed increased amounts of endpoint
pyoverdine in both the 1% glucose media and 2% glucose media compared to the 0% glucose
media. This suggests that in line with a previous publication, that we were indeed increasing
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biofilm density as our data presented above showed that increasing biofilm density increased
pyoverdine production [71]. Moreover, it demonstrates that we could influence pyoverdine
production through non-genetic intervention. Overall, these data suggests that the ability to perturb
pyoverdine production through periodic disturbance is not limited to a single parameter (one strain,
one growth rate, one biofilm density) and instead may be observable in strains and environments
that lead to diverse biofilm densities.
Based upon this observation, we extended our analysis to 20 different strains isolated from
a clinic. After characterizing the ability of these strains to form biofilms, and their growth rate, we
concluded that by using these strains, we could test our hypotheses over a wide range of growth
parameters. Note that due to the different environments from which these strains were isolated,
they all likely have different pyoverdine synthesis rates, and genetic differences. We note that the
former was challenging to measure after repeated attempts whereas the latter is likely true based
on a preliminary analysis of genomic sequence (not shown).
In general, we observed the greatest change to pyoverdine amounts in the 1% glucose
condition (Fig. 14). This was evidenced a reduced R2 value between pyoverdine produced in the
undisturbed and 6 shakes/hr condition and the large number of individual strains that showed a
significant change in pyoverdine owing to shaking. When we examined the change in the
distribution of bacteria grown in medium with increasing glucose, we observed that 1) as the
concentration of glucose in the medium increased, the amount of bacteria in the biofilm owing to
shaking increased and 2) the amount of bacteria in the planktonic state owing to shaking was
greatest when the medium contained 1% glucose. Moreover, when we examined changes in the
density of bacteria in the biofilm and planktonic states owing to shaking, we found that when the
medium contained 1% glucose, there was a significant decrease in the amount of bacteria in the
biofilm state owing to shaking (Fig. 15).
Based on these observations, we propose the following to account for the large change in
pyoverdine amount owing to shaking in bacteria grown in medium with 1% glucose. When
bacteria are grown in 0% glucose, they form overall weak biofilms. In these weak biofilms,
perturbation with shaking only has a modest effect as the biofilms are less dense. In contrast, when
growing in medium with 2% glucose media, bacteria produce robust biofilms, which are more
resilient to perturbation through shaking. Thus, in both conditions, the number of strains with
altered pyoverdine amounts as a result of shaking is relatively low. In contrast when bacteria were
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grown in medium with 1% glucose, these biofilms are at an intermediate point between weak and
robust. In this state, the biofilms are more easily perturbed, which results in a significant reduction
in biofilm density. This coincides with a significant increase in the density of bacteria in the
planktonic state. Because changing glucose does not change growth rate (across percentages of
glucose examined in this study), bacteria in planktonic state and in 1% glucose have no additional
advantage relative to their 0% and 2% glucose counterparts. Thus, although these bacteria can
access additional nutrients, some strains cannot compensate for the reduction in pyoverdine
accessibility owing to a reduction in biofilm structure. Thus, the amount of pyoverdine synthesized
under this condition can decrease.
While the aforementioned hypothesis can account for reduction in a pyoverdine owing to
shaking, it cannot explain instances of increased pyoverdine production. Indeed, a large number
of strains showed an observable increase in the amount of pyoverdine synthesized owing to
shaking (Fig. 18). These individual reaction norms are interesting and warrants further study.
Initial possible changes include different pyoverdine expression rates, changes in the efficiency of
pyoverdine to uptake and import iron, or other changes related to biofilm formation. Further
research on this topic will continue in the lab using a bioinformatics approach to examine genetic
differences in strains and explore how those differences impact changes in biofilm density and
endpoint pyoverdine in the 6 shake/hr condition.
In future studies, we suggest investigating how periodic disturbance to biofilm structure
impacts quorum sensing and the expression of virulence factors in P. aeruginosa. As quorum
sensing is mediated by several diffusible metabolites, it is likely that periodic disturbance will also
alter the relative position of these metabolites and bacteria, and thus could impact quorum sensing
regulated expression of virulence factors. Moreover, as shaking clearly affected biofilm structure,
it would be interesting to examine the combination of shaking and the application of pyoverdine
inhibitors or antibiotics. Of particular note, shaking could increase the ability of these drugs to
penetrate the biofilm, which would serve to augment their affect.
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Table 1: Strains used in this study.

Strain name

Source

PA14

American Type Culture
Collection

PA14 (-pel)

Dr. Roberto Kolter

PA + eGFF

This study

EnvKY1
PAK
Shr42
PA1651
PA1414
MRSN1344
PA1400
MX0560
MRSN994
MRSN1380
MRSN317

BEI Resources

MRSN1356
MRSN17849
MRSN16847
MRSN16383
MRSN16344
MRSN1601
MRSN552
MRSN1583
MRSN1388

39

Lid
Peg
Biofilm
Well
Planktonic
Bacteria

Linear Shaking

Figure 1: An experimental approach to disturbing the spatial structure of biofilms. We used
the Innovotech MBEC Biofilm Inoculator to grow biofilms. After growing biofilms, we used the
linear shaking function of a plate reader to disturb the distribution of bacteria in the biofilm. In
general, bacteria will be removed from the biofilm and enter the planktonic state. The distribution
of bacteria already in the planktonic state will also be perturbed.
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Figure 2: Using crystal violet (measured at OD555), we confirmed the presence of biofilms on
the peg of the MBEC Biofilm Inoculator using our growth procedure (see Methods). Standard
deviation from 5 biological replicates (two-tailed t-test, P = 0.0001).
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Figure 3: The density of bacteria in the biofilm and planktonic states before and after a single
shaking event. Left panel: absolute cell density (biofilm, P = 0.21, planktonic, = 0.015, two-tailed
t-test). Right panel: planktonic cell density normalized by biofilm cell density (P = 0.014, twotailed t-test). Standard deviation from three biological replicates.
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Figure 4: The density of bacteria in the planktonic state as the amplitude of shaking is
increased (P < 0.02 for all comparisons, two-tailed t-test). R2 reported from the fit of a linear
line. Standard deviation from three biological replicates.
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Figure 5: Periodically disturbing biofilms of P. aeruginosa strain PA14 can reduce the
amount of pyoverdine. The amount of pyoverdine in growth medium with 0% glucose after
periodically disturbing biofilms. In both panels, pyoverdine (measured using
emit

excite

= 405 nm and

= 460 nm, a.u.) normalized by OD600 and biofilms were disturbed for 24 hours. Average from

a minimum of 4 replicates. * indicates statistical difference between unshaken and 30 shakes per
hour using two-tailed t-test (P < 0.016).
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Figure 6: The quantity of pyoverdine in liquid medium and in cells growing in a biofilm on
the pegged lid of the MBEC biofilm inoculator plates. We grew biofilms over 24 hours in media
with 0% glucose and measured pyoverdine in both the planktonic bacteria as well as in the biofilm
by resuspending the biofilm in media to measure it. Pyoverdine (measured using excite = 405 nm
and emit = 460 nm, a.u.) normalized by OD600. The majority of pyoverdine was found in liquid
media in the well surrounding the peg (two-tailed t-test, P = 0.008). Standard deviation from five
replicates.
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Figure 7: The amount of green fluorescent protein (GFP) in growth medium after
periodically disturbing the spatial structure of biofilms containing P. aeruginosa expressing
gfp for 24 hours. GFP (a.u.) normalized by cell density (OD600). We did not observe a significant
change in normalized GFP across between frequencies of unshaken (0 shakes/hr) and 6 shakes/hr
(two-tailed t-test, P =0.84). We did observe a significant decrease in GFP when 30 shakes/hr was
compared to 6 shakes/hr (P = 0.0002, two-tailed t-test) and the unshaken control (0 shakes/hr, P =
0.018). Standard deviation from four replicates. GFP and cell density measured from liquid
medium in well.
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Figure 8: The effect of periodic shaking on normalized pyoverdine in a strain of P. aeruginosa
(-pel) that lacked the ability to form biofilms. Standard deviation from 5 replicates.
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Figure 9: Inclusion of 10uM of gallium in the growth medium reduced the amount of
pyoverdine synthesized. Furthermore, it did not result in a reduction of pyoverdine due to periodic
shaking. Standard deviation from 5 replicates.
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Figure 10: Average growth rate of P. aeruginosa strain PA14 in medium with increasing
glucose as measured using CFU. Growth rate measured using CFU as described in Methods.
Increasing glucose did not alter the average growth rate (P  0.15, two-tailed t-test, all
comparisons). Standard deviation from a minimum of 3 biological replicates.
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Figure 11: The amount of pyoverdine in growth medium with increasing percentage of
glucose after periodically disturbing biofilms. * indicates statistical difference between
unshaken and 30 shakes per hour using two-tailed t-test (P  0.014, two-tailed t-test, all conditions).
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Figure 12: Growth characteristics of P. aeruginosa strains isolated from the clinic. A) The
density of biofilms in the absence of shaking of different strains of P. aeruginosa as measured
using crystal violet (OD555). Standard deviation from three biological replicates. B) Average
growth rate of P. aeruginosa strains as measured using OD600 in medium with increasing
percentages of glucose. Standard deviation from three biological replicates.
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Figure 13: An intermediate percentage of glucose in the growth medium decreases the
strength of a linear relationship between pyoverdine in an undisturbed and a periodically
disturbed condition. Linear correlation between pyoverdine produced under unshaken (0
shakes/hr) and periodically disturbed (6 shakes/hr) conditions in medium with 0% glucose. For
panels A-C, average plotted from six biological replicates. Indicated P value is from a linear
regression analysis. R2 reported after plotting a linear line through the data.
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Figure 14: The average amount of pyoverdine synthesized by strains of P. aeruginosa in the

undisturbed and 6 shake/hr conditions in medium with increasing percentages of glucose. In

each panel (A = 0% glucose, B = 1% glucose, C = 2% glucose) standard deviation from 6

replicates. Pyoverdine normalized by cell density (OD600).
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Figure 15: Change in biofilm density as a result of shaking at 6 shakes/hr as a function of
percentage of glucose in the growth medium. Biofilm density measured at OD555 after staining
with crystal violet. In panels D and E, we subtracted the 6 shakes/hr condition from the unshaken
(0/hr) condition. * indicates significantly different using a two-tailed t-test (P < 0.009, all
conditions compared).
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Figure 16: Change in the density of planktonic bacteria as a result of shaking at 6 shakes/hr
as a function of percentage of glucose in the growth medium. Bacteria in the planktonic state
measured using OD600. To calculate change in biofilm density we subtracted the 6 shakes/hr
condition from the unshaken (0/hr) condition. * indicates significantly different using a two-tailed
t-test (0% glucose vs. 1% glucose, 1% glucose vs. 2% glucose, P < 0.001, 0% glucose vs. 2%
glucose, P = 0.64).
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Figure 17: The relationship between difference in pyoverdine amount between undisturbed
and 6 shakes/hr as a function of growth rate. No linear correlation was found with any
condition. R2 values from fit of linear line. Standard deviation from three replicates.
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Figure 18: A significant reduction in biofilm density at intermediate percentage of glucose
can result in a significant change in pyoverdine density. Number of P. aeruginosa strains that
had a significant decrease in the amount of pyoverdine as a result of periodic disturbance at 6/hr.
Significance determined using a two-tailed t-test comparing 0/hr and 6/hr within each percentage
of glucose. Insert: Number of strains that had a significance increase (striped bars) or decrease
(dotted bars) in the amount of pyoverdine.
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Figure 19: Change in biofilm density as a result of shaking at 6 shakes/hr as a function of
percentage of glucose in the growth medium. Strains with a significant change in pyoverdine
post shaking are indicated with dotted bars; strains with an insignificant change in pyoverdine
indicated with striped bars. Biofilm density measured at OD555 after staining with crystal violet.
* indicates statically significant decrease in pyoverdine using a one-tailed test (P = 0.049).
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Figure 20: Change in the density of planktonic bacteria as a result of shaking at 6
shakes/hr as a function of percentage of glucose in the growth medium. Strains with a
significant change in pyoverdine post shaking are indicated with dotted bars; strains with an
insignificant change in pyoverdine indicated with striped bars. Bacteria in the planktonic state
measured using OD600.
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